This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Fazeela Morshed: Innovator in Recombinant Gas Vesicles
Introduction: Fazeela Morshed is an accomplished inventor based in Amherst, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant gas vesicles. Her innovative work has the potential to advance medical research and therapeutic applications.
Latest Patents: Fazeela Morshed holds a patent for her invention titled "Recombinant gas vesicles and uses thereof." This invention features a composition that includes substantially pure recombinant gas vesicles, which have at least one heterologous peptide inserted into one of their structural proteins. When administered to a mammal, these recombinant gas vesicles can elicit antibodies that specifically bind to the heterologous peptide. The heterologous peptide can be any peptide against which one wishes to raise antibodies, such as a peptide found in the gp120 protein of human immunodeficiency virus (HIV). This patent showcases her innovative approach to addressing complex biological challenges.
Career Highlights: Fazeela Morshed is affiliated with the University of Massachusetts, where she continues her research and development efforts. Her work is characterized by a commitment to advancing scientific knowledge and improving health outcomes through innovative solutions.
Collaborations: Fazeela has collaborated with notable colleagues, including Shiladitya DasSarma and Elizabeth S. Stuart. These collaborations have enriched her research and contributed to the advancement of her projects.
Conclusion: Fazeela Morshed is a pioneering inventor whose work on recombinant gas vesicles holds promise for future medical applications. Her contributions to biotechnology exemplify the impact of innovation in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
